RASGRP3 and central nervous system neoplasm: Currently, numerous studies identified within non-WNT/non-SHH MB two “consensus” molecular groups designated as Grp3 and Grp4 MB with their further subdivision into multiple subgroups through I to VIII, which were included in the latest edition of the WHO CNS tumor classification [2, 5–7, 10–12].